According to a new report published by K D Market Insights, titled, “Coagulation analyzers Market Insights, Trends, Opportunity Forecast, 2023–2032,” the global coagulation analyzers market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. the increasing prevalence of blood disorders, advancements, in technology the growing elderly population and the healthcare industries adoption of automation. Additionally point of care testing has become increasingly popular which are the major factors augmenting the growth of the global coagulation analyzers market. The global coagulation analyzers market is anticipated to grow at a high CAGR of 5.7% from 2023 to 2032. The market's revenue surged to $4.2 billion in 2022, and it is expected to further accelerate, reaching a notable $7.3 billion by 2032.

The rising prevalence of blood disorders, like hemophilia and thrombosis is fueling the need for reliable equipment, are further expected to create ample growth opportunities for the global coagulation analyzers market during the forecast period i.e., 2023-2032. Moreover, the growing elderly population presents opportunity, has propelled market expansion. adoption of automation in healthcare, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global coagulation analyzers market in 2022. The region is further projected to continue dominating in the market during the forecast period. This can be attributed to the emphasis on healthcare and medical research activities in hospitals and clinics.

According to product, the clinical laboratory analyzers segment accounted for the largest market share in the coagulation analyzers market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global coagulation analyzers market is segmented into product, test, technology, end-users and region. Based on product, the market is bifurcated into clinical laboratory analyzers, and point of care analyzers. Based on test, it is classified into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimer testing, platelet function tests, anti-factor xa tests, heparin protamine dose-response tests for act, other coagulation tests. Based on technology, it is classified into optical, mechanical, electrochemical, and others. Based on end-users, it is classified into clinical laboratories, hospitals, other end users.

The global coagulation analyzers market is analyzed across North America (U.S. Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East Africa).

Key Insights of Coagulation Analyzers Market

• On the basis of product, the clinical laboratory analyzers segment accounted for the largest market share in the coagulation analyzers market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
• On the basis of region, North America accounted for the largest share in the global coagulation analyzers market in 2022. The region is further projected to continue dominating in the market during the forecast period.
• On the basis of region, Europe is estimated to account for the second largest share in the market during the forecast period.

Some of the major coagulation analyzers companies profiled in the report include Helena Laboratories, Instrumentation Laboratory (Werfen Group), Thermo Fisher Scientific Inc., International Technidyne Corporation (ITC), Siemens Healthcare (AG), Nihon Kohden Corporation, Roche Diagnostics (F. Hoffmann-La Roche Ltd.), Alere Inc., Sysmex Corporation, Diagnostica Stago Sas.

Related Reports :-

https://www.kdmarketinsights.com/reports/uveitis-treatment-market/3310

https://www.kdmarketinsights.com/reports/animal-healthcare-market/3294

https://www.kdmarketinsights.com/reports/e-clinical-solution-software-market/3268

https://www.kdmarketinsights.com/reports/nootropics-market/3212

https://www.kdmarketinsights.com/reports/dyslipidemia-therapeutics-market/3070